Advance Agrolife Reports Q2 Revenue of ₹2.87B Versus ₹2.13B YoY

Market snapshot: Advance Agrolife Limited reported its second-quarter financial results for FY27, highlighting top-line growth driven by higher market traction. Consolidated revenue from operations reached ₹287 crore (₹2.87B), demonstrating expansion over the corresponding period last year.

Data Snapshot

• Q2 FY27 revenue from operations stood at ₹287 crore (₹2.87B), compared to ₹213 crore (₹2.13B) in Q2 FY26.
• Q2 FY27 EBITDA reached ₹21.8 crore (₹218M), compared to ₹25.9 crore (₹259M) YoY, with EBITDA margin declining to 7.59% from 12.18%.
• Net profit for Q2 FY27 was recorded at ₹11.8 crore (₹118M), versus ₹15.9 crore (₹159M) reported in Q2 FY26.

What's Changed

• Revenue expanded ≈34.74% YoY (derived: ₹287 crore vs ₹213 crore).
• EBITDA margin contracted by 459 bps YoY to 7.59% from 12.18%.
• Net profit contracted ≈25.79% YoY (derived: ₹11.8 crore vs ₹15.9 crore).

Key Takeaways

• Top-line expansion highlights healthy volume uptake in core agrochemical formulations during the quarter.
• Margin compression suggests elevated raw material cost pressures or operational input headwinds affecting EBITDA.
• Net earnings performance highlights the operational leverage trade-off between volume growth and margin control.

SAHI Perspective

Advance Agrolife's performance indicates robust demand execution on the top line, with revenue advancing over 34% YoY. However, bottom-line contraction reflects pricing pressures and higher input costs in the sector. Management focus on margin stabilization will remain critical for near-term earnings recovery.

Market Implications

The mixed earnings report presents a dual dynamic: strong revenue expansion demonstrates market share gains, while margin contraction may limit near-term valuation re-rating until cost efficiencies are restored.

Trading Signals

Market Bias: Neutral

Advance Agrolife delivered strong top-line revenue growth of ₹287 crore (up from ₹213 crore YoY), but operating margin compression to 7.59% and lower net profit of ₹11.8 crore balance out the immediate market bias.

Overweight: Agrochemical Formulations

Underweight: High Input-Cost Chemical Processing

Trigger Factors:

• Sustained quarterly revenue growth above ₹250 crore
• Recovery of EBITDA margins back toward double-digit levels (>10%)
• Raw material input price moderation in global chemical supply chains

Time Horizon: Near-term (0-3 months)

Industry Context

The agrochemicals and crop protection sector in India continues to benefit from seasonal Kharif demand, though volatile global active ingredient prices have created margin pressures across mid-tier formulators.

Key Risks to Watch

• Continued margin compression from raw material price volatility
• Geographic or seasonal concentration in agricultural sales cycles
• Working capital expansion tied to credit terms for distribution channels

Recent Developments

No verified developments in this window

Closing Insight

While top-line momentum remains healthy, achieving cost efficiency and restoring operating margins above 10% will be pivotal for sustaining long-term earnings growth.

High Performance Trading with SAHI.